This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Celebrating the Innovations of Elisabetta Galbiati
Introduction: Elisabetta Galbiati, located in Parma, Italy, is a remarkable inventor known for her contributions to the field of pharmaceuticals. With a focus on innovative solutions for postmenopausal pathologies, her work exemplifies the spirit of modern invention that seeks to improve health and well-being.
Latest Patents: Elisabetta holds a patent for "2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof." This innovation specifically addresses the preparation and application of these derivatives in pharmaceutical compositions aimed at preventing and treating postmenopausal conditions. The significance of this patent extends to its potential impact on women's health.
Career Highlights: Currently, Elisabetta is employed at Chiesi Farmaceutici S.p.A., a leading pharmaceutical company recognized for its commitment to research and innovation in healthcare. Her role involves pioneering research that pushes the boundaries of existing treatments and opens new avenues for therapeutic interventions.
Collaborations: Throughout her career, Elisabetta has collaborated with esteemed colleagues, including Maurizio Delcanale and Gabriele Amari. These partnerships reflect a collaborative spirit in scientific research, facilitating knowledge sharing and combined expertise to advance healthcare solutions.
Conclusion: Elisabetta Galbiati’s contributions to the field of pharmaceuticals underscore the importance of innovation in addressing health challenges. Her patented work serves as a testament to her dedication as an inventor and her commitment to improving the quality of life for women facing postmenopausal issues. As the medical field continues to evolve, the contributions of innovators like Elisabetta will undoubtedly play a crucial role in shaping the future of healthcare and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
